The Guardian: FDA reverses course and will review Moderna’s mRNA-based flu vaccine
Following backlash after it initially refused to review Moderna’s mRNA influenza vaccine, the US Food and Drug Administration (FDA) will now review the vaccine.
Moderna submitted an application for the FDA to approve the new product in December 2025. Other countries, including Australia, accepted the vaccine for review. The FDA’s initial refusal to review the vaccine sparked concerns about the influence of the current administration.
Read the full article at The Guardian: FDA reverses course and will review Moderna’s mRNA-based flu vaccine.
Updated immunisation reference page: Specialist immunisation services
MVEC’s Specialist immunisation services page was recently updated to include details of the new antenatal vaccination service at Northern Health.
Find more details about the new service at MVEC: Specialist immunisation services.
ABC: Parents fail to return consent forms as Far North Queensland HPV vaccination rate drops
Queensland’s HPV vaccination rates have declined since 2019. Public health experts are concerned about particularly low vaccination rates in some areas, pointing to systemic issues causing students to miss vaccines.
Read the article in full at ABC: Parents fail to return consent forms as Far North Queensland HPV vaccination rate drops.
Read more about human papillomavirus at MVEC: HPV.
Victorian Department of Health: Ongoing measles alert
The health alert for increased travel-related measles cases in Victoria remains open. The health alert includes a list of public exposure sites and details about the current risk of measles. Measles cases have also been reported in other jurisdictions (including NSW, Qld, SA और WA).
Read Victoria’s measles alert in full at Increased travel-related measles cases in Victoria.
Vaccination is the best way to protect yourself and others against measles. Read more about measles disease, transmission, epidemiology and prevention at एमवीईसी: खसरा.
WHO: Myth-busters: debunking long COVID myths and misconceptions
The World Health Organization (WHO) has developed 8 myth-busters and accompanying resources to counter misinformation about long COVID.
Share campaign materials to help debunk myths and misconceptions. Read more and access materials at WHO: Myth-busters: debunking long COVID myths and misconceptions.
Read more about COVID-19 disease at एमवीईसी: कोविड-19.
Australian CDC: Nipah Virus Infection Situation Update
On 9 February the Australian Centre for Disease Control (CDC) published its latest situation update on Nipah virus infection in West Bengal, India and Rajshahi, Bangladesh. The report includes details about the current situation and its relevance to Australia, and details about Nipah virus epidemiology.
Read the full report here: Australian CDC Situation update: Nipah virus infection in West Bengal, India and Rajshahi, Bangladesh
Benchmarque Group: Upcoming virtual workshops
Benchmarque Group will host 2 virtual workshops on the topic of immunisation catchup. Learn more and register for workshops via the event pages linked below.
Basic Catchups for Immunisation: 23 April 2026
Complex Catchups for Immunisation: 30 April 2026
Learn more about immunisation catchups at MVEC: Catch-up immunisation
Spleen Australia webinar: Living Without a Spleen: Translating Guidelines into Everyday Care
तिल्ली ऑस्ट्रेलिया presents this practical, case-based webinar, designed to support GPs and other healthcare providers to confidently apply current Australian recommendations and integrate Spleen Australia into routine primary care workflows.
तारीख: 17 March 2026
समय: 6:00–8:00 pm (AEDT)
Registration details:
https://us02web.zoom.us/j/88438345169?pwd=T9yEIvM3Ppq0xouzAgMURfJHKHuuTh.1
Meeting ID - 88438345169
Password - 3VZ7QU
WHO webinar: Real-World Evidence on RSV Vaccines and Monoclonal Antibodies: Effectiveness, Surveillance, and Early Implementation Insights
This upcoming World Health Organization webinar will share early real-world evidence on RSV prevention product effectiveness, genomic surveillance findings on breakthrough infections, and key programmatic lessons from early adopting countries.
तारीख: 25 February 2026
समय: 9:00–10:30 am (CET) (7:00–8:30 pm AEDT)
Learn more about RSV disease, transmission, epidemiology and prevention at MVEC: RSV
Victorian Department of Health: Nurse immunisers approved to administer MMR vaccines to infants from 6 months of age
Victoria’s Chief Health Officer has approved एनurse मैंmmunser-led administration of measles-containing vaccines to infants from 6 months of age who are travelling overseas. This authorisation है in accordance with ATAGI recommendations.
Victorian Department of Health: Nurse immunisers – approved client groups